压缩式吸入器雾化吸入布地奈德治疗幼儿哮喘临床研究

Compression type of budesonide in the treatment of infantile asthma inhaler inhalationof clinical research

目的研究经压缩式吸入器吸入布地奈德雾化悬液治疗幼儿哮喘的临床疗效。方法选取自我院2013年5月～2014年5月收治的60例年龄小于5岁的哮喘患者作为研究对象，对患者给予压缩式吸入器雾化吸入布地奈德悬液治疗。比较治疗后1～4周患者的治疗状况。结果患者接受治疗1～4周后，总有效率分别为：96．7％、98．4％、100％，相比较明显高于第1周治疗后的总控制率（85％）。治疗1～4周后效果进行比较，差异具有统计学意义（P〈0．05）。结论5岁以下的支气管哮喘患儿在接受压缩式吸入器雾化吸入布地奈德治疗后，疗效显著，患儿哮喘控制率得到了明显的提高，操作简单且安全性较强，在儿科临床上可进行推广使用。

Objective Study on the clinical efficacy of compression type inhaler inhalation of budesonide suspension in treatment ofchildren asthma. Methods Selected self hospital from 2013 to 2014 60 patients under the age of 5 asthma patients as the research object, given compression type inhaler aerosol inhalation of budesonide suspension treatment on patients. 1-4 weeks after treatment, patients of treatment status. Results Patients undergoing treatment for 2-4 weeks, the total control rate respectively is 96.7%, 98.4%, 100%,compared to the first week of treatment was higher than that of the total control rate after 85%. Comparison ofl-4 weeks after the treatment effect, with statistically significant difference （P〈O.05）. Conclusion 5 years old of the following children with bronchial asthma inhaler in acceptable compression atomization inhalation of budesonide treatment, the curative effect is remarkable, asthma control rate has been significantly improved, the operation is simple and strong safety, in the pediatric clinical practice to promotethe use of